MingSight Pharmaceuticals Inc, Pfizer deal

Pfizer granted MingSight exclusive, worldwide rights to develop and commercialize two undisclosed compounds. Both compounds are in preclinical testing for diabetic retinopathy and other ophthalmic ind...